Molecular Imaging最新文献

筛选
英文 中文
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL 高suv在转移性前列腺癌患者中具有更强的重复性:来自18F-DCFPyL成像的前瞻性测试-再测试队列的结果
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2022-02-23 DOI: 10.1155/2022/7056983
R. Werner, Bilêl Habacha, S. Lütje, Lena Bundschuh, T. Higuchi, P. Hartrampf, S. Serfling, T. Derlin, C. Lapa, A. Buck, M. Essler, K. Pienta, M. Eisenberger, M. Markowski, Laura K. Shinehouse, Rehab Abdallah, A. Salavati, M. Lodge, M. Pomper, M. Gorin, R. Bundschuh, S. Rowe
{"title":"High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL","authors":"R. Werner, Bilêl Habacha, S. Lütje, Lena Bundschuh, T. Higuchi, P. Hartrampf, S. Serfling, T. Derlin, C. Lapa, A. Buck, M. Essler, K. Pienta, M. Eisenberger, M. Markowski, Laura K. Shinehouse, Rehab Abdallah, A. Salavati, M. Lodge, M. Pomper, M. Gorin, R. Bundschuh, S. Rowe","doi":"10.1155/2022/7056983","DOIUrl":"https://doi.org/10.1155/2022/7056983","url":null,"abstract":"Objectives In patients with prostate cancer (PC) receiving prostate-specific membrane antigen- (PSMA-) targeted radioligand therapy (RLT), higher baseline standardized uptake values (SUVs) are linked to improved outcome. Thus, readers deciding on RLT must have certainty on the repeatability of PSMA uptake metrics. As such, we aimed to evaluate the test-retest repeatability of lesion uptake in a large cohort of patients imaged with 18F-DCFPyL. Methods In this prospective, IRB-approved trial (NCT03793543), 21 patients with history of histologically proven PC underwent two 18F-DCFPyL PET/CTs within 7 days (mean 3.7, range 1 to 7 days). Lesions in the bone, lymph nodes (LN), and other organs were manually segmented on both scans, and uptake parameters were assessed (maximum (SUVmax) and mean (SUVmean) SUVs), PSMA-tumor volume (PSMA-TV), and total lesion PSMA (TL-PSMA, defined as PSMA − TV × SUVmean)). Repeatability was determined using Pearson's correlations, within-subject coefficient of variation (wCOV), and Bland-Altman analysis. Results In total, 230 pairs of lesions (177 bone, 38 LN, and 15 other) were delineated, demonstrating a wide range of SUVmax (1.5–80.5) and SUVmean (1.4–24.8). Including all sites of suspected disease, SUVs had a strong interscan correlation (R2 ≥ 0.99), with high repeatability for SUVmean and SUVmax (wCOV, 7.3% and 12.1%, respectively). High SUVs showed significantly improved wCOV relative to lower SUVs (P < 0.0001), indicating that high SUVs are more repeatable, relative to the magnitude of the underlying SUV. Repeatability for PSMA-TV and TL-PSMA, however, was low (wCOV ≥ 23.5%). Across all metrics for LN and bone lesions, interscan correlation was again strong (R2 ≥ 0.98). Moreover, LN-based SUVmean also achieved the best wCOV (3.8%), which was significantly reduced when compared to osseous lesions (7.8%, P < 0.0001). This was also noted for SUVmax (wCOV, LN 8.8% vs. bone 12.0%, P < 0.03). On a compartment-based level, wCOVs for volumetric features were ≥22.8%, demonstrating no significant differences between LN and bone lesions (PSMA-TV, P =0.63; TL-PSMA, P =0.9). Findings on an entire tumor burden level were also corroborated in a hottest lesion analysis investigating the SUVmax of the most intense lesion per patient (R2, 0.99; wCOV, 11.2%). Conclusion In this prospective test-retest setting, SUV parameters demonstrated high repeatability, in particular in LNs, while volumetric parameters demonstrated low repeatability. Further, the large number of lesions and wide distribution of SUVs included in this analysis allowed for the demonstration of a dependence of repeatability on SUV, with higher SUVs having more robust repeatability.","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2022-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42806885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
89Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NFκB and JNK Signaling 肿瘤PD-1的89Zr免疫PET成像揭示PMA通过NFκB和JNK信号上调淋巴瘤PD-1
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2022-02-12 DOI: 10.1155/2022/5916692
Kyung-Ho Jung, Jin Hee Lee, Mina Kim, Y. Cho, Kyung-Han Lee
{"title":"89Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NFκB and JNK Signaling","authors":"Kyung-Ho Jung, Jin Hee Lee, Mina Kim, Y. Cho, Kyung-Han Lee","doi":"10.1155/2022/5916692","DOIUrl":"https://doi.org/10.1155/2022/5916692","url":null,"abstract":"Immune therapy of T-cell lymphoma requires assessment of tumor-expressed programmed cell death protein-1 (PD-1). Herein, we developed an immuno-PET technique that quantitatively images and monitors regulation of PD-1 expression on T-cell lymphomas. Methods. Anti-PD-1 IgG underwent sulfhydryl moiety-specific conjugation with maleimide-deferoxamine and 89Zr labeling. Binding assays and Western blotting were performed in EL4 murine T-cell lymphoma cells. In vivo pharmacokinetics, biodistribution, and PET were performed in mice. Results. 89Zr-PD-1 IgG binding to EL4 cells was completely blocked by cold antibodies, confirming excellent target specificity. Following intravenous injection into mice, 89Zr-PD-1 IgG showed biexponential blood clearance and relatively low normal organ uptake after five days. PET/CT and biodistribution demonstrated high EL4 tumor uptake that was suppressed by cold antibodies. In EL4 cells, phorbol 12-myristate 13-acetate (PMA) increased 89Zr-PD-1 IgG binding (305.5 ± 30.6%) and dose-dependent augmentation of PD-1 expression (15.8 ± 3.8 − fold of controls by 200 ng/ml). FACS showed strong PD-1 expression on all EL4 cells and positive but weaker expression on 41.6 ± 2.1% of the mouse spleen lymphocytes. PMA stimulation led to 2.7 ± 0.3-fold increase in the proportion of the strongest PD-1 expressing EL4 cells but failed to influence that of PD-1+ mouse lymphocytes. In mice, PMA treatment increased 89Zr-PD-1 IgG uptake in EL4 lymphomas from 6.6 ± 1.6 to 13.9 ± 3.6%ID/g (P = 0.01), and tumor uptake closely correlated with PD-1 level (r = 0.771, P < 0.001). On immunohistochemistry of tumor sections, infiltrating CD8α+ T lymphocytes constituted a small fraction of tumor cells. The entire tumor section showed strong PD-1 staining that was even stronger for PMA-treated mice. Investigation of involved signaling revealed that PMA increased EL4 cell and tumor HIF-1α accumulation and NFκB and JNK activation. Conclusion. 89Zr-PD-1 IgG offered high-contrast PET imaging of tumor PD-1 in mice. This was found to mostly represent binding to EL4 tumor cells, although infiltrating T lymphocytes may also have contributed. PD-1 expression on T-cell lymphomas was upregulated by PMA stimulation, and this was reliably monitored by 89Zr-PD-1 IgG PET. This technique may thus be useful for understanding the mechanisms of PD-1 regulation in lymphomas of living subjects.","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2022-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44768329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Positron Emission Tomography (PET) with 18F-FGA for Diagnosis of Myocardial Infarction in a Coronary Artery Ligation Model 正电子发射断层扫描(PET)与18F-FGA诊断冠状动脉结扎模型心肌梗死
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2022-02-09 DOI: 10.1155/2022/9147379
V. Awasthi, H. Gali, A. Hedrick, Huining Da, Venkateswararao Eeda, D. Jain
{"title":"Positron Emission Tomography (PET) with 18F-FGA for Diagnosis of Myocardial Infarction in a Coronary Artery Ligation Model","authors":"V. Awasthi, H. Gali, A. Hedrick, Huining Da, Venkateswararao Eeda, D. Jain","doi":"10.1155/2022/9147379","DOIUrl":"https://doi.org/10.1155/2022/9147379","url":null,"abstract":"Location and extent of necrosis are valuable information in the management of myocardial infarction (MI). Methods. We investigated 2-deoxy-2-18F-fluoro glucaric acid (FGA), a novel infarct-avid agent, for positron emission tomography (PET) of MI. We synthesized FGA from commercially available 18F-fluoro-2-deoxy-2-D-glucose (FDG). MI was induced in mice by permanently occluding the left anterior descending coronary artery. Biodistribution of FGA was assessed 1 h after FGA injection (11 MBq). PET/CT was conducted 1 h, 6 h, 1 d, 3 d, and 4 d after MI. Subcellular compartment of FGA accumulation in necrosis was studied by tracing the uptake of biotin-labeled glucaric acid with streptavidin-HRP in H2O2-treated H9c2 cardiomyoblasts. Streptavidin-reactive protein bands were identified by LC-MS/MS. Results. We obtained a quantitative yield of FGA from FDG within 7 min (radiochemical purity > 99%). Cardiac uptake of FGA was significantly higher in MI mice than that in control mice. Imaging after 1 h of FGA injection delineated MI for 3 days after MI induction, with negligible background signal from surrounding tissues. Myocardial injury was verified by tetrazolium staining and plasma troponin (47.63 pg/mL control versus 311.77 pg/mL MI). In necrotic H9c2 myoblasts, biotinylated glucaric acid accumulated in nuclear fraction. LC-MS/MS primarily identified fibronectin in necrotic cells as a putative high fidelity target of glucaric acid. Conclusion. FGA/PET detects infarct early after onset of MI and FGA accumulation in infarct persists for 3 days. Its retention in necrotic cells appears to be a result of interaction with fibronectin that is known to accumulate in injured cardiac tissue.","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2022-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45576454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Synchrotron-Based Dynamic Lung Imaging 基于同步加速器的动态肺成像
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2021-01-01 DOI: 10.1016/b978-0-12-816386-3.00014-4
S. Dubsky
{"title":"Synchrotron-Based Dynamic Lung Imaging","authors":"S. Dubsky","doi":"10.1016/b978-0-12-816386-3.00014-4","DOIUrl":"https://doi.org/10.1016/b978-0-12-816386-3.00014-4","url":null,"abstract":"","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54192961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell Surveillance Using Magnetic Resonance Imaging 利用磁共振成像技术进行细胞监测
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2021-01-01 DOI: 10.1016/b978-0-12-816386-3.00042-9
B. Helfer, J. Bulte
{"title":"Cell Surveillance Using Magnetic Resonance Imaging","authors":"B. Helfer, J. Bulte","doi":"10.1016/b978-0-12-816386-3.00042-9","DOIUrl":"https://doi.org/10.1016/b978-0-12-816386-3.00042-9","url":null,"abstract":"","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":"38 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54193904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnetic Resonance Fingerprinting: Basic Concepts and Applications in Molecular Imaging 磁共振指纹识别:基本概念及其在分子成像中的应用
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2021-01-01 DOI: 10.1016/b978-0-12-816386-3.00067-3
Kathleen M. Ropella-Panagis, N. Seiberlich
{"title":"Magnetic Resonance Fingerprinting: Basic Concepts and Applications in Molecular Imaging","authors":"Kathleen M. Ropella-Panagis, N. Seiberlich","doi":"10.1016/b978-0-12-816386-3.00067-3","DOIUrl":"https://doi.org/10.1016/b978-0-12-816386-3.00067-3","url":null,"abstract":"","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54194269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PET Imaging in Cancer Clinical Trials PET成像在癌症临床试验中的应用
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2021-01-01 DOI: 10.1016/b978-0-12-816386-3.00082-x
D. Mankoff
{"title":"PET Imaging in Cancer Clinical Trials","authors":"D. Mankoff","doi":"10.1016/b978-0-12-816386-3.00082-x","DOIUrl":"https://doi.org/10.1016/b978-0-12-816386-3.00082-x","url":null,"abstract":"","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54194803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular and Functional Imaging in Central Nervous System Drug Development 中枢神经系统药物开发中的分子和功能成像
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2021-01-01 DOI: 10.1016/b978-0-12-816386-3.00084-3
B. Künnecke, M. Honer, G. Pagano, M. Rudin
{"title":"Molecular and Functional Imaging in Central Nervous System Drug Development","authors":"B. Künnecke, M. Honer, G. Pagano, M. Rudin","doi":"10.1016/b978-0-12-816386-3.00084-3","DOIUrl":"https://doi.org/10.1016/b978-0-12-816386-3.00084-3","url":null,"abstract":"","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54195085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small-Animal SPECT, SPECT/CT, and SPECT/MRI 小动物SPECT, SPECT/CT和SPECT/MRI
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2021-01-01 DOI: 10.1016/b978-0-12-816386-3.00007-7
L. Meng, N. Clinthorne
{"title":"Small-Animal SPECT, SPECT/CT, and SPECT/MRI","authors":"L. Meng, N. Clinthorne","doi":"10.1016/b978-0-12-816386-3.00007-7","DOIUrl":"https://doi.org/10.1016/b978-0-12-816386-3.00007-7","url":null,"abstract":"","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":"11 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54192917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hybrid PET-CT-Ultrasound Imaging pet - ct -超声混合成像
IF 2.8 4区 医学
Molecular Imaging Pub Date : 2021-01-01 DOI: 10.1016/b978-0-12-816386-3.00020-x
B. Tavitian, M. Pérez-Liva
{"title":"Hybrid PET-CT-Ultrasound Imaging","authors":"B. Tavitian, M. Pérez-Liva","doi":"10.1016/b978-0-12-816386-3.00020-x","DOIUrl":"https://doi.org/10.1016/b978-0-12-816386-3.00020-x","url":null,"abstract":"","PeriodicalId":49796,"journal":{"name":"Molecular Imaging","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54193110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信